Clincosm LogoSign in Get a demo

Ependymoma

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AI R&D Tool in Adult Glioma and Other Primary Brain Tumours

Not yet recruiting
  • Brain Tumor
  • +4 more
  • Resection
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 15, 2023

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Radiation Therapy in Pediatric Central Nervous System Tumors

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023

    Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

    Active, not recruiting
    • Malignant Glioma
    • +2 more
    • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
    • Concurrent Optune and RT followed by Optune System alone
    • Los Angeles, California
    • +8 more
    Jan 17, 2023

    Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

    Recruiting
    • Medulloblastoma
    • +5 more
      • Beijing, Beijing, China
        Beijing Tiantan Hosiptal
      Jan 3, 2023

      Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

      Recruiting
      • Ependymoma
      • +3 more
      • Augusta, Georgia
        Augusta University, Georgia Cancer Center
      Dec 16, 2022

      CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

      Recruiting
      • Central Nervous System Tumor
      • +10 more
      • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

      Recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • HER2-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022

      Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

      Completed
      • Ependymoma
      • +9 more
      • Nivolumab
      • NKTR-214
      • Little Rock, Arkansas
      • +17 more
      Dec 8, 2022

      Ependymoma Trial in Memphis, Toronto (radiation, procedure, drug, device)

      Active, not recruiting
      • Ependymoma
      • Irradiation
      • +5 more
      • Memphis, Tennessee
      • +1 more
      Oct 28, 2022

      Ependymoma Trial in Pittsburgh (biological, drug, other)

      Recruiting
      • Ependymoma
      • HLA-A2 restricted synthetic tumor antigen
      • +5 more
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh of UPMC
      Oct 23, 2022

      Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

      Recruiting
      • Glioblastoma
      • +3 more
      • Augusta, Georgia
      • +2 more
      Aug 18, 2022

      High Grade Glioma, Ependymoma Trial in Orlando, Hackensack (Optune NovoTTF-200A System)

      Recruiting
      • High Grade Glioma
      • Ependymoma
      • Optune NovoTTF-200A System
      • Orlando, Florida
      • +1 more
      Aug 12, 2022

      Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

      Recruiting
      • Medulloblastoma
      • +7 more
      • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
      • +2 more
      • Buffalo, New York
      • +2 more
      Jul 8, 2022

      Rare CNS Tumors Outcomes &Risk

      Recruiting
      • High Grade Meningioma
      • +4 more
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Jul 6, 2022

        Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)

        Recruiting
        • Astrocytoma
        • +11 more
        • ProTRAIT
        • Maastricht, Limburg, Netherlands
        • +2 more
        Apr 12, 2022

        Ependymoma Trial in New York (HER2 Specific CAR T Cell)

        Recruiting
        • Ependymoma
        • HER2 Specific CAR T Cell
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Apr 6, 2022

        Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

        Recruiting
        • Ependymoma
        • +3 more
        • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
        • Duarte, California
          City of Hope Medical Center
        Mar 9, 2022

        Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma Trial in Worldwide (radiation, drug, other)

        Active, not recruiting
        • Anaplastic Ependymoma
        • +5 more
        • 3-Dimensional Conformal Radiation Therapy
        • +7 more
        • Birmingham, Alabama
        • +208 more
        Mar 7, 2022

        Brain Metastasis, Spinal Tumors, Lung Tumors Trial in France (SBRT treatment)

        Completed
        • Brain Metastasis
        • +3 more
        • SBRT treatment
        • Nice, Alpes Maritimes, France
        • +14 more
        Mar 7, 2022

        CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

        Recruiting
        • Central Nervous System Neoplasms
        • +22 more
        • Bethesda, Maryland
          National Institutes of Health
        Mar 1, 2022

        Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)

        Not yet recruiting
        • Glioma
        • +12 more
        • Observational
        • (no location specified)
        Feb 17, 2022

        Ependymoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

        Terminated
        Has Results
        • Ependymoma
        • Antineoplaston therapy (Atengenal + Astugenal)
        • Houston, Texas
          Burzynski Clinic
        Feb 18, 2022

        Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)

        Active, not recruiting
        • Ependymoma, Recurrent Childhood
        • Ependymoma
        • Granulocyte Macrophage Colony Stimulation Factor
        • Denver, Colorado
        • +1 more
        Feb 8, 2022